14666 results for "PLOS+ONE+Pennsylvania+German+ACS+language+code+pdc+open+access+study"

in 17.19 milliseconds.

• PREDICT

  PREDICT/Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics.

  Study EGAS00001000094

• Res1_PC9_exp2_MC_01_04_22

  8 cell pellet samples for genomic DNA extraction. CRISPR PCR1 and PCR2 indexing - Please use standard Kosuke primers.

  Study EGAS00001006170

• 850k Methyome analysis of snap frozen or FFPE stored human MBM

  We performed a 850k infinium bead chip-based global methylome analysis of MBM.

  Study EGAS00001005975

• Germline variants in patients diagnosed with both uveal and cutaneous melanoma

  We sequenced the constitutional DNA from patients affected by both uveal and cutaneous melanoma.

  Study EGAS00001007584

• 30X_WGS_sequencing_of_100_individuals_from_the_general_Greek_population

  This project entailed generation of high depth WGS (30x) of 100 individuals from the general Greek population.

  Study EGAS00001000988

• Whole_exome_sequencing_CHD_trios

  Whole exome sequencing of families with Congenital Heart Defects (182 trios). Collaboration with David Brook, University of Nottingham.

  Study EGAS00001000808

• Lung_Progression_versus_Regression_Whole_Genome_Sequencing

  Around 50 samples of pre-invasive lung cancer lesions showing subsequent clinical and pathological progression or regression

  Study EGAS00001000837

• Neuroblastoma tumors by bulk RNAseq, from Berlanga et al, 2022

  To prouve the relevance of the use of PDX models derived from patient's tumors.

  Study EGAS00001007161

• Delineating intratumoural heterogeneity and neoantigen-directed immune escape in Esophageal Squamous Cell Carcinoma

  Delineating intratumoural heterogeneity and neoantigen-directed immune escape in Esophageal Squamous Cell Carcinoma

  Study EGAS00001003832

• The_identification_of_genetic_vulnerabilities_in_head_and_neck_cancers_for_the_development_of_novel_therapies

  CRISPR/Cas9 lethality screens in a set of Asian head and neck cancer cell lines to identify novel targets.

  Study EGAS00001002204